219: The business case for going green

August 20th, 2024  |  26 mins 57 secs

health policy, provider strategy and financial outlook

In this episode, host Abby Burns invites Advisory Board climate change expert Miles Cottier to break down how and why healthcare business leaders need to prioritize environmental sustainability. They explore the financial case for moving to renewable energy sources, how regulatory pressures may (or may not) shape the future of environmental action, and what leaders can do today to support their green initiatives.

218: [Encore + bonus content] Site-of-care shifts: It's time to go on offense

August 13th, 2024  |  37 mins 18 secs

provider strategy and financial outlook, service lines

This week, host Abby Burns invites Advisory Board expert Sebastian Beckmann back to Radio Advisory to provide an update—as promised—on what his team has uncovered about site-of-care shifts in the six months since he first brought this research to the pod. Hint: he argues there’s about $50B at play. This episode is a modified encore of Episode 195: Site-of-care shifts: It’s time to go on offense,” with bonus content from Abby and Sebastian.

[Encore] Test, fail, and test again: Morgan Health's approach to employer costs

August 6th, 2024  |  38 mins 54 secs

In this episode, host Rachel Woods invites Advisory Board payer expert Max Hakanson and Morgan Health innovation lead Rivka Friedman to discuss what employers can do to rein in healthcare costs, both for themselves and their employees.

[Encore] Why can't providers and plans just get along?

July 30th, 2024  |  31 mins 10 secs

In this episode, host Abby Burns invites Advisory Board experts Max Hakanson and Eileen Fennell to get to the bottom of escalating tensions between health plans and providers and give a peek behind the curtain of what their research suggests it will take for the two stakeholders to improve their relationships.

217: How to make innovation real: Live from Advisory Board's Clinical Innovation Summit

July 23rd, 2024  |  38 mins 32 secs

clinical innovation and affordability, external guests, tech and ai

In this episode, live from Advisory Board's 2024 Clinical Innovation Summit, guest host and Advisory Board digital health expert John League invites Dr. Ayo Ajaiyeoba from Blue Cross Blue Shield of Kansas City, and Elliot Green, cofounder and CEO of Dandelion Health, to share their ideas of what thoughtful, intentional innovation looks like and how to effectively navigate discussions with vendors and payers.

216: Why providers and employers need to focus on women's health "beyond the bikini"

July 16th, 2024  |  28 mins 10 secs

health equity, service lines

In this episode, host Rachel Woods invites Advisory Board women’s health experts Kara Marlatt and Gaby Marmolejos to explain why providers and employers need to expand their focus on women’s health to include the post-reproductive years, and explore what tangible steps they can take to do so today.

215: Why Walmart and other retailers are exiting primary care delivery and why it matters

July 9th, 2024  |  28 mins 13 secs

industry consolidation

Large retailers like CVS, Walgreens, and Walmart have been steadily growing their care delivery footprints over the last several years—but recent developments suggest that the tide may be turning.

In the wake of Walmart’s late April announcement that it’s closing down its primary care operations, host Abby Burns invites Advisory Board experts Vidal Seegobin, Natalie Trebes, and Eliza Dailey to push past the headlines and decipher why Walmart and other retailers are now retrenching on primary care delivery investments. And, of course, what this means for incumbent providers.

Behind the scenes: Our journey to four years, 1M downloads

July 2nd, 2024  |  31 mins 29 secs

Host Rachel Woods and the Radio Advisory production team celebrate one million downloads by looking back at some of their favorite episodes and the lessons learned along the way.

214: Is Governance the answer to AI integration? Duke says yes.

June 25th, 2024  |  31 mins 32 secs

external guests, provider strategy and financial outlook, tech and ai

In this episode, host Rachel Woods invites Duke University Health System's Chief Information Officer, Dr. Eric Poon, to discuss how Duke has approached the ethical implementation of AI across and why the right governance structure is essential.

213: Radio Advisory Live: Why "value" doesn't have to be zero sum, with Stacey Richter

June 18th, 2024  |  41 mins 25 secs

clinical innovation and affordability, external guests, leadership, value-based care

In this episode, recorded live at Advisory Board’s 2024 Value Summit in New Orleans, host Abby Burns invites Stacey Richter, healthcare entrepreneur, co-president of Aventria Health Group, and host of the Relentless Health Value podcast, to unpack what “value” in healthcare actually means and what it will take to improve value across the industry.

212: Lessons from the C-Suite: Google's Chief Health Officer Dr. Karen DeSalvo on healthcare's cognitive industrial revolution

June 11th, 2024  |  45 mins 59 secs

external guests, leadership, tech and ai

In this episode, Dr. Karen DeSalvo, Chief Health Officer at Google, sits down with guest host Eric Larsen, President Emeritus of Advisory Board and President of Towerbrook Advisors, to unpack the seemingly boundless opportunities of generative AI to evolve healthcare and the unique—and scoped—role Google is playing in helping advance that evolution.

211: Pursuing financial sustainability in cell and gene therapy delivery

June 4th, 2024  |  28 mins 41 secs

clinical innovation and affordability, provider strategy and financial outlook

The conversation around cell and gene therapies often centers on payers and purchasers, and the challenge of financing access to these expensive treatments. But there’s a key stakeholder missing from that discussion: the providers. In the final episode of our series on bespoke care and innovation, host Rachel Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to highlight the delivery side of the equation and unpack how providers are grappling with how to get these life-changing treatments to those that need them: patients.